Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oramed Pharmaceuticals Inc. - Common Stock (NQ:ORMP)

4.225 -0.145 (-3.32%)
Delayed Quote Updated: 1:32 PM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Oramed Pharmaceuticals Inc. - Common Stock

News headline image
Lifeward Successfully Closes on Strategic Partnership with Oramed
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
Investment comes at a pivotal moment for Alpha Tau, which is experiencing remarkable growth on multiple fronts, with four active U.S. trial approvals, expansion into multiple internal organ... 
From Alpha Tau Medical Ltd.
Via GlobeNewswire
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.